| NCT04574583 | National Cancer Institute (NCI) | Metastatic Cancer|Solid Tumors | 2020-11-24 | PHASE1|PHASE2 |
| NCT03554473 | National Cancer Institute (NCI) | Carcinoma, Small Cell|Lung Cancer|Small Cell Lung Cancer | 2018-09-11 | PHASE1|PHASE2 |
| NCT04296942 | National Cancer Institute (NCI) | Breast Cancer|Triple Negative Breast Cancer|HER2&addition; Breast Cancer|Hormone Receptor Negative Breast Cancer|Metastatic Breast Cancer | 2021-05-04 | PHASE1 |
| NCT04417660 | National Cancer Institute (NCI) | Thymic Epithelial Tumor|Recurrent Thymoma|Thymic Cancer | 2020-12-26 | PHASE2 |
| NCT04432597 | National Cancer Institute (NCI) | HPV Positive Cancer|Vulvar, Vaginal, Penile, Rectal Cancer|Anal Cancer|Oropharyngeal Cancer|Cervical Cancer | 2020-08-11 | PHASE1|PHASE2 |
| NCT03840915 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Carcinoma, Non-Small-Cell Lung | 2019-04-02 | PHASE1|PHASE2 |
| NCT04297748 | Olivia Newton-John Cancer Research Institute|Merck Healthcare KGaA|Austin Health | Non-Small Cell Lung Cancer | 2020-06-01 | PHASE1|PHASE2 |
| NCT03840902 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Non-small Cell Lung Cancer | 2019-04-16 | PHASE2 |
| NCT04633252 | National Cancer Institute (NCI) | Cancer Of Prostate|Prostate Neoplasms | 2021-02-23 | PHASE1|PHASE2 |
| NCT04247282 | National Cancer Institute (NCI) | Head and Neck Cancer|Head and Neck Neoplasms | 2020-06-09 | PHASE1|PHASE2 |
| NCT03707587 | National Cancer Institute (NCI) | Recurrent Respiratory Papillomatosis|Respiratory Papillomatosis|Laryngeal Papilloma, Recurrent|Human Papilloma Virus | 2018-12-19 | PHASE2 |
| NCT04501094 | National Cancer Institute (NCI) | Urothelial Cancer | 2020-10-26 | PHASE2 |
| NCT04551950 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Cervical Cancer | 2020-10-19 | PHASE1 |
| NCT03631706 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Non-small Cell Lung Cancer | 2018-10-01 | PHASE3 |
| NCT03427411 | National Cancer Institute (NCI) | Human Papilloma Virus|Cervical Cancer|Oropharyngeal Cancer|Anal Cancer|Vaginal or Penile Cancer | 2018-02-27 | PHASE2 |
| NCT04287868 | National Cancer Institute (NCI) | Cervical Cancer|HPV Cancers|Anal Cancer|Oropharyngeal Cancer|Vulvar, Vaginal, Penile, Rectal Cancer | 2020-06-09 | PHASE1|PHASE2 |
| NCT03833661 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Biliary Tract Cancer|Cholangiocarcinoma|Gallbladder Cancer | 2019-03-26 | PHASE2 |
| NCT03436563 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Colon Adenocarcinoma|High-Frequency Microsatellite Instability|Metastatic Malignant Solid Neoplasm|Rectal Adenocarcinoma|Refractory Colorectal Carcinoma|Stage IV Colon Cancer AJCC v8|Stage IV Rectal Cancer AJCC v8|Stage IVA Colon Cancer AJCC v8|Stage IVA Rectal Cancer AJCC v8|Stage IVB Colon Cancer AJCC v8|Stage IVB Rectal Cancer AJCC v8 | 2018-03-07 | PHASE1|PHASE2 |
| NCT04303117 | National Cancer Institute (NCI) | Kaposi Sarcoma | 2020-07-13 | PHASE1|PHASE2 |
| NCT03315871 | National Cancer Institute (NCI) | Prostate Cancer | 2018-03-20 | PHASE2 |
| NCT04327986 | National Cancer Institute (NCI) | Histologically or Cytologically Confirmed Pancreatic Cancer|Unresectable or Borderline Resectable Pancreatic Cancer|Pancreatic Neoplasms|Pancreatic Cancer|Metastatic Pancreatic Cancer | 2021-06-15 | PHASE1|PHASE2 |
| NCT04066491 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Biliary Tract Cancer|Cholangiocarcinoma|Gallbladder Cancer | 2019-09-20 | PHASE2|PHASE3 |
| NCT05445882 | National Cancer Institute (NCI) | Castration Resistant Prostate Cancer | 2024-04-01 | PHASE2 |
| NCT04457778 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Metastatic Solid Tumors | 2020-07-10 | PHASE1 |
| NCT04648826 | National Cancer Institute (NCI) | Sarcomas|Melanomas|Germ Cell Tumors|Epithelial Malignancies (Excluding Lung and Renal Cell Carcinomas)|Pulmonary Metastases | 2021-12-14 | PHASE1|PHASE2 |
| NCT04349280 | GlaxoSmithKline|Merck KGaA, Darmstadt, Germany | Neoplasms | 2020-10-15 | PHASE1 |
| NCT04756505 | M.D. Anderson Cancer Center | Anatomic Stage IV Breast Cancer AJCC v8|Hormone Receptor Positive Breast Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic HER2 Negative Breast Adenocarcinoma|Prognostic Stage IV Breast Cancer AJCC v8 | 2021-03-07 | PHASE1 |
| NCT04489940 | EMD Serono Research & Development Institute, Inc.|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Triple Negative Breast Neoplasms | 2020-10-12 | PHASE2 |
| NCT04708470 | National Cancer Institute (NCI) | Oropharyngeal Cancer|Neck Cancer|Human Papillomavirus|HPV|Anal Cancer|Cervical Cancer|Penile Cancer|Vulvar Cancer|Vaginal Cancer|Colon Cancer | 2021-10-05 | PHASE1|PHASE2 |
| NCT04971187 | M.D. Anderson Cancer Center | Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma|Metastatic Lung Non-Squamous Non-Small Cell Carcinoma|Stage III Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Unresectable Lung Non-Squamous Non-Small Cell Carcinoma | 2021-06-30 | PHASE2 |
| NCT04220775 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Recurrent Head and Neck Squamous Cell Carcinoma|Second Primary Squamous Cell Carcinoma of the Head and Neck | 2020-03-18 | PHASE1|PHASE2 |
| NCT04246489 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Uterine Cervical Neoplasms | 2020-03-30 | PHASE2 |
| NCT04878250 | Queen Mary University of London | Transitional Cell Carcinoma|Bladder Cancer | 2021-06 | PHASE2 |
| NCT04560686 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Resectable Lung Non-Small Cell Carcinoma|Stage I Lung Cancer AJCC v8|Stage IA1 Lung Cancer AJCC v8|Stage IA2 Lung Cancer AJCC v8|Stage IA3 Lung Cancer AJCC v8|Stage IB Lung Cancer AJCC v8|Stage II Lung Cancer AJCC v8|Stage IIA Lung Cancer AJCC v8|Stage IIB Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8 | 2020-08-05 | PHASE2 |
| NCT03524170 | M.D. Anderson Cancer Center | Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8 | 2018-04-30 | PHASE1 |
| NCT02723955 | GlaxoSmithKline|Merck Sharp & Dohme LLC | Neoplasms | 2016-06-23 | PHASE1 |
| NCT04727541 | AIO-Studien-gGmbH|Merck Serono GmbH, Germany | Biliary Tract Cancer|Cholangiocarcinoma | 2021-07-08 | PHASE2 |
| NCT04789668 | M.D. Anderson Cancer Center | Anatomic Stage IV Breast Cancer AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Hematopoietic and Lymphoid Cell Neoplasm|Hormone Receptor Positive Breast Adenocarcinoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Neoplasm in the Brain|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Triple-Negative Breast Carcinoma|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8 | 2021-01-15 | PHASE1|PHASE2 |
| NCT04396886 | The University of Hong Kong|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Nasopharyngeal Carcinoma|Recurrent Carcinoma|Metastatic Cancer|Non-keratinizing Carinoma | 2020-02-27 | PHASE2 |
| NCT04708067 | M.D. Anderson Cancer Center | Locally Advanced Intrahepatic Cholangiocarcinoma|Metastatic Intrahepatic Cholangiocarcinoma|Stage III Intrahepatic Cholangiocarcinoma AJCC v8|Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8|Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8|Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | 2021-08-31 | PHASE1 |
| NCT04396535 | Mayo Clinic | Advanced Lung Non-Small Cell Carcinoma|Stage III Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8 | 2020-10-23 | PHASE2 |
| NCT05061823 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Lung Cancer|Cancer | 2021-12-01 | PHASE3 |
| NCT04481256 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|UMC Utrecht|Catharina Ziekenhuis Eindhoven|Institute Verbeeten|Elisabeth-TweeSteden Ziekenhuis|Leiden University Medical Center|Radiotherapeutic Institute Friesland|Frisius Medisch Centrum|Radiotherapy Group Deventer|Deventer Ziekenhuis|Rijnstate Hospital|Erasmus Medical Center|The Netherlands Cancer Institute|Isala|University Medical Center Groningen|Ziekenhuisgroep Twente | Carcinoma, Squamous Cell|Oesophageal Cancer | 2020-11-11 | NA |
| NCT04874311 | Institut Bergonié|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Advanced Soft-tissue Sarcoma|Metastatic Soft-tissue Sarcoma | 2022-03-01 | PHASE2 |
| NCT03579472 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8 | 2018-05-30 | PHASE1 |
| NCT04428047 | UNICANCER|Merck KGaA, Darmstadt, Germany | Squamous Cell Carcinoma of Head and Neck | 2021-02-04 | PHASE2 |
| NCT03620201 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8 | 2018-08-03 | PHASE1 |
| NCT05005429 | Fundación GECP | Mesothelioma; Lung | 2021-09-20 | PHASE2 |
| NCT02699515 | Merck KGaA, Darmstadt, Germany | Solid Tumors | 2016-03-11 | PHASE1 |
| NCT02517398 | EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany | Solid Tumors | 2015-08-31 | PHASE1 |
| NCT04491955 | National Cancer Institute (NCI) | Small Bowel Cancers|Colorectal Cancers | 2020-09-22 | PHASE2 |